A Tumor initiating cell-enriched prognostic signature for HER2(+):ERα(−) breast cancer; rationale, new features, controversies and future directions

The high intra- and inter-tumor heterogeneity of many types of cancers, including breast cancer (BC), poses great challenge to development of subtype-specific prognosis. In BC, the classification of tumors as either ERα(+) (Luminal A and Luminal B), HER2(+) (ERα(+) or ERα(−)) or triple-negative (TNB...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Liu, Jeff C., Egan, Sean E., Zacksenhaus, Eldad
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2013
Gaiak:
Research Perspective
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787160/
https://ncbi.nlm.nih.gov/pubmed/23945331
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak